Codexis director awarded 66,350 stock options

CODEXIS, INC. director Rahul Singhvi was granted a stock option covering 66,350 shares of common stock.

Accepted by SEC EDGAR 06/18/2026 - 04:51 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

CODEXIS, INC. director Rahul Singhvi was granted a stock option covering 66,350 shares of common stock. The option has an exercise price of $2.48 per share and expires on June 17, 2036.

The award vests in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, as long as he continues serving as a director on that vesting date. Following this grant, his option holdings from this award total 66,350 shares.

Insider Trade Summary

Grant/Award: 66,350 shares

Grant/Award 1 txn

Insider Singhvi Rahul

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	66,350	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 66,350 options (Direct)

Holdings Before and After: Stock Option (Right to Buy), 0 to 66,350 options (Direct)

Footnotes (1)

1. F1. This option vests and becomes exercisable with respect to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date.

Key Figures

Option grant size: 66,350 shares Exercise price: $2.48 per share Expiration date: June 17, 2036 +1 more

4 metrics

Option grant size 66,350 shares Stock option covering Codexis common stock

Exercise price $2.48 per share Option exercise price for the 66,350 shares

Expiration date June 17, 2036 Option expiration for this grant

Post-grant option holdings for this award 66,350 shares Total shares following transaction for this option

Key Terms

Stock Option (Right to Buy), exercise price, expiration date, annual stockholder meeting, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

exercise price financial

"conversion_or_exercise_price: 2.4800"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2036-06-17T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

annual stockholder meeting financial

"on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting"

An annual stockholder meeting is a yearly gathering where a company's owners (shareholders) receive updates on performance, vote on key issues like board members, executive pay and major corporate plans, and ask questions of management. Think of it as a company town hall where choices about oversight and direction are decided; outcomes can affect management accountability, corporate strategy and ultimately the value and risks of investors’ shares.

continued service financial

"subject to the director's continued service to the Company on such vesting date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Codexis (CDXS) director Rahul Singhvi report on this Form 4?

Rahul Singhvi reported receiving a stock option grant for 66,350 shares of Codexis common stock. This is a compensation-related award, not an open-market share purchase or sale, and reflects additional equity-based incentives tied to his board service.

How many Codexis (CDXS) shares are covered by the new option grant?

The new option grant covers 66,350 shares of Codexis common stock. All 66,350 shares are tied to a single option award reported as a derivative security, with the same number of underlying common shares referenced in the filing’s transaction details.

What is the exercise price and expiration date of Rahul Singhvi’s Codexis option?

The option has an exercise price of $2.48 per share and expires on June 17, 2036. This means he can choose to buy Codexis shares at $2.48 any time after vesting and before the June 17, 2036 expiration date.

When does the new Codexis (CDXS) option grant to Rahul Singhvi vest?

The option vests in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting. Vesting is conditioned on his continued service as a director through that vesting date, according to the footnote description.

Is this Codexis Form 4 a market buy or sell of CDXS shares?

No, this Form 4 does not show an open-market buy or sell. It reports a grant of a stock option as director compensation, with 66,350 underlying shares and no shares bought or sold in the market in this particular transaction.

How many Codexis option shares does Rahul Singhvi hold after this grant?

After this reported grant, the filing shows 66,350 option shares tied to this award. The total_shares_following_transaction field for the derivative security matches 66,350 shares, indicating the full size of this newly granted option position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Singhvi Rahul

(Last) (First) (Middle)

246 HOLLY DRIVE

200 PENOBSCOT DRIVE

(Street)

REDWOOD CITY CALIFORNIA 94063

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CODEXIS, INC. [ CDXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.48	06/17/2026		A		66,350		(1)	06/17/2036	Common Stock	66,350	$0	66,350	D

Explanation of Responses:

1. This option vests and becomes exercisable with respect to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date.

	/s/ Georgia Erbez, as Attorney-in-Fact for Rahul Singhvi	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)